TABLE 1.
Condition (target) | [3H]arachidonic acid release (% total cell content) |
[3H]GroPIns production (% total water-soluble [3H]inositol cell content) |
||||
---|---|---|---|---|---|---|
Unstimulated | FcR-phagocytosis | LPS | Unstimulated | FcR-phagocytosis | LPS | |
Control | 1.93 ± 0.17a | 1.95 ± 0.18a | 14.88 ± 0.61b | 18.03 ± 2.56b | ||
0.5 μm Pyr (PLA2IVα) | 0.98 ± 0.04 | 0.97 ± 0.08c | 0.97 ± 0.08a | 5.44 ± 0.79 | 8.04 ± 0.81b | 6.34 ± 0.85b |
1 μm BEL (PLA2VI) | 1.03 ± 0.06 | 2.00 ± 0.08 | 1.55 ± 0.10 | 6.42 ± 0.41 | 16.33 ± 0.01 | 19.91 ± 0.81 |
50 μm sPLA2IIA inhibitor-I (sPLA2) | 1.16 ± 0.07 | 2.10 ± 0.04 | 1.69 ± 0.27 | 10.31 ± 1.05 | 21.14 ± 0.01 | 20.54 ± 2.76 |
10 μm SB203580 (p38) | 1.30 ± 0.11 | 1.35 ± 0.06c | 1.83 ± 0.32 | 6.08 ± 0.62 | ND | 13.49 ± 2.56 |
10 μm U0126 (ERK1/2) | 1.16 ± 0.28 | 1.25 ± 0.04c | 1.08 ± 0.17b | 5.81 ± 0.62 | ND | 6.39 ± 0.62b |
10 μm SP600125 (JNK) | 1.16 ± 0.04 | 1.20 ± 0.03a | 2.61 ± 0.04 | ND | ND | ND |
10 μm SB203580 + 10 μm U0126 (p38 + ERK1/2) | ND | 0.87 ± 0.15c | ND | ND | ND | ND |
a p < 0.001 (Student's t test), with respect to their relevant controls.
b p < 0.05 (Student's t test), with respect to their relevant controls.
c p < 0.02 (Student's t test), with respect to their relevant controls.